![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0256.jpg)
/
Stage I NSCLC
: No dose effect relationship for 15-33Gy
Brain metastases
: Higher efficacy of SRT vs SRS
Guckenberger Radiother Oncol 2013
Single fraction SRS versus fractionated
stereotactic radiotherapy
SBRT for stage I NSCLC
Shuryak Radiother Oncol 2015
SRS for brain metastases
13.06.2016
Matthias Guckenberger - ESTRO SBRT Course 2016 Athens
14